Reducing differences in the uptake of immunisations - additional consultation on the evidence

NICE was asked by the Department of Health (DH) to develop public health intervention guidance to reduce differences in the uptake of immunisations (including targeted vaccines) in children and young people aged under 19 years. The scope is available from the guidance summary page.

All registered stakeholders are now invited to comment on the evidence that has been assembled to inform the development of this guidance. This evidence was used by the Public Health Interventions Advisory Committee (PHIAC) to develop draft guidance. The evidence comprises a revised analysis of the evidence and three economic analyses. The revised analysis is based on an evidence review issued for stakeholder consultation from 24 September - 22 October 2008 and includes changes to the evidence tables in response to that consultation.

Key areas for comment

The aim of this consultation is to enable stakeholders to consider the revised analysis of the evidence, the revised evidence tables and three economic analyses and to provide the opportunity to comment, in particular on:

  • queries around the interpretation of the evidence, both of single studies and the reviewed material as a whole
  • the applicability of the evidence and its usefulness for the continued development of guidance
  • issues relating to equality
  • issues relating to cost-effectiveness

The consultation on this evidence will run from 5 May to 2 June 2009.

Please provide all responses to this consultation on the evidence electronically using the Stakeholder Comments Form (ensuring all relevant fields are completed, including your organisation's name) and forward this, by 5pm on Tuesday 2 June at the very latest to the following email address:

Consultation Documents

The revised analysis of the evidence was carried out by NICE.

The revised evidence tables were produced by the National Collaborating Centre for Women’s and Children’s Health.

Economic analyses 1 and 3 were carried out by the London School of Hygiene and Tropical Medicine.

Economic analysis 2 was carried out by the National Collaborating Centre for Women’s and Children’s Health.

Please note, the evidence presented here does not constitute the Institute's guidance on this topic. NICE has issued draft guidance on reducing differences in the uptake of immunisations.

This page was last updated: 30 March 2010